SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Ocular Therapeutix, Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapies for diseases and conditions of the eye. Its product pipeline includes Dextenza, OTX-TP, and OTX-TIC. The company was founded by Amarpreet S. Sawhney and Farhad Khosravi on September 12, 2006 and is headquartered in Bedford, MA.

Ocular Therapeutix Inc

Ocular Therapeutix (OCUL) is trending amid escalating rumors of an enhanced acquisition offer from Sanofi, which previously rejected a $16/share bid, coupled with high anticipation for imminent Phase 3 data for AXPAXLI in wet AMD. The recent hire of Eylea's former architect as CCO further fuels community discussion about a potential premium buyout or successful independent launch.

The Compound Governance Token is a governance token on the Compound Finance lending protocol, COMP allows the owner to delegate voting rights to the address of their choice; the owner’s wallet, another user, an application, or a DeFi expert. Anybody can participate in Compound governance by receiving delegation, without needing to own COMP.  Anybody with 1% of COMP delegated to their address can propose a governance action; these are simple or complex sets of actions, such as adding support for a new asset, changing an asset’s collateral factor, changing a market’s interest rate model, or changing any other parameter or variable of the protocol that the current administrator can modify.

Compound

Compound (COMP CRYPTO) is a hot topic as its community debates its future amidst recent partnerships, V4 development, and the launch of the Legend app, which proponents believe could drive a significant rebound in the DeFi lending protocol. While bulls highlight limited token supply and new utility in the RWA space, skeptics point to historical underperformance and ongoing governance challenges as major headwinds.

Jack in the Box, Inc. engages in the provision of developing, operating, and franchising a chain of quick-service and fast-casual restaurants. It operates through the Jack in the Box and Del Taco segments. The Jack in the Box segment offers a selection of distinctive products including classic burgers and other product lines such as Buttery Jack Burgers. The company was founded by Robert Oscar Peterson in 1951 and is headquartered in San Diego, CA.

Jack In The Box, Inc.

Jack in the Box is a battleground stock as the announced Del Taco sale aims to address its heavy debt, while an activist investor's increasing stake drives community debate over a potential short squeeze versus looming bankruptcy for the struggling restaurant chain.

TOSHI

TOSHI is drawing significant community attention, with many anticipating an imminent breakout and substantial price appreciation driven by bullish technical indicators and its prominent status as the "face of Base" ecosystem. Investors are actively discussing accumulation and higher targets as the coin trends across platforms.

Genius Sports Ltd. engages in the provision of scalable, technology-led products and services to the sports, sports betting, and sports media industries. It also involves in Sports League, which offers technology infrastructure for the collection, integration, and distribution of live data; Sportsbooks, which includes collection of live sports data, odds making, risk management and player marketing; and Sports Media, which provides a range of online marketing and fan engagement tools. The company was founded by Mark Adrian Locke in 2000 and is headquartered in London, United Kingdom.

Genius Sports Limited

Genius Sports is trending after a controversial $1.2 billion acquisition of Legend, which has triggered a significant sell-off fueled by community concerns over perceived overpayment, increased debt, and dilution, overshadowing the company's strong underlying business performance amid broader sector uncertainty.

ZIM Integrated Shipping Services Ltd. engages in the provision of shipping and logistics services. It offers shipping solutions, including the transportation of out-of-gauge cargo, refrigerated cargo, and dangerous and hazardous cargo. The company was founded on June 7, 1945 and is headquartered in Haifa, Israel.

Zim Integrated Shipping Services Ltd

ZIM Integrated Shipping is trending amid intense buyout speculation, as its board rejected a "significantly undervalued" CEO-led offer and evaluates multiple competitive acquisition proposals. The community is anticipating a higher price, with some highlighting the company's strong cash reserves and current elevated container shipping rates.

ProShares Trust - ProShares Ultra Bloomberg Crude Oil 2x Shares

ProShares Ultra Bloomberg Crude Oil

Escalating geopolitical tensions in the Middle East and Latin America, alongside ongoing disruptions to Russian oil infrastructure, are driving intense community debate on potential crude supply shortages. Many traders are closely monitoring these developments, anticipating a significant upside move for oil-related assets.

$Goldcoin: the gold standard on Solana. All PumpFun CTO Creator Rewards are allocated 50% for buybacks &amp; burns and 50% for marketing + development daily. Full transparent CTO leadership providing on-chain + social proof evidence of all transactions. We provide provide daily Token Improvement Reports that highlight all the reward claims, allocations, showing 50% buyback and burn transactions, and all marketing expense transactions for $Goldcoin every day.  Community CTO involved in voting and decision-making as often as possible.

goldcoin

Daily token burns and development efforts are driving conversation around GOLDCOIN, as the community actively discusses its potential as a Solana-based digital gold, citing its low market cap and fully diluted supply as key factors for substantial upside.

Renaissance Capital Greenwich Funds - Renaissance IPO ETF

The Renaissance IPO ETF is trending amid a significant uptick in new public offerings, including various biotech, tech, and SPAC listings, signaling a potential "IPO wave" returning to the market. However, community discussion reveals mixed sentiment, with some highlighting strong post-debut performances while others express concern over substantial declines in other recent listings and the overall sector's recent underperformance.

Okta, Inc. engages in the provision of an identity management platform for enterprises. It operates through the United States and International geographical segments. The firm's products include single sign-on, multi-factor authentication, access gateway, API access management, authentication, adaptive MFA and lifecycle management. The company was founded by Todd McKinnon and J. Frederic Kerrest in 2009 and is headquartered in San Francisco, CA.

Okta Inc - Ordinary Shares - Class A

Okta Inc

Okta is actively discussed after a strong Q3 earnings beat and the authorization of a $1 billion share buyback, leading to analyst upgrades and community optimism about its AI agent security potential. Despite this, some investors remain perplexed by the stock's recent price action, citing a lack of explicit long-term guidance as a point of contention amidst broader software sector trends.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Nascent Biotech, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of monoclonal antibodies for the treatment of various forms of cancer. It focuses on biologic drug candidates that are undergoing or have already completed initial clinical testing for the treatment of cancer and then seek to further develop those drug candidates for commercial use. Its products include Pritumumab, CLNH5, and MultiPharm. The company was founded by Mark C. Glassy on March 3, 2014 and is headquartered in North Palm Beach, FL.

Nascent Biotech Inc

3%+ above current levels

Up 0–3%

Flat to down 3%

Down 3%+

The Nasdaq 100 continues to hinge on mega-cap tech and AI strength. With rate expectations shifting and valuations stretched, even a 3% move could signal a bigger trend. Is momentum building, or fading?

NBIO
Nascent Biotech Inc

Feed

News

Sentiment

Fundamentals

Info

Poll

Latest NBIO News

NBIONascent Biotech Inc